These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 3534582)
1. Review of Canadian trials of adjuvant endocrine therapy for breast cancer. Meakin JW NCI Monogr; 1986; (1):111-3. PubMed ID: 3534582 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. Goldhirsch A; Gelber R NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016 [TBL] [Abstract][Full Text] [Related]
3. Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer. Tormey DC; Gray R; Taylor SG; Knuiman M; Olson JE; Cummings FJ NCI Monogr; 1986; (1):75-80. PubMed ID: 3534593 [TBL] [Abstract][Full Text] [Related]
4. Assessment of adjuvant trials in breast cancer. Zelen M; Gelman R NCI Monogr; 1986; (1):11-7. PubMed ID: 3774010 [TBL] [Abstract][Full Text] [Related]
5. Ovarian ablation as treatment for young women with breast cancer. Davidson NE J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032 [TBL] [Abstract][Full Text] [Related]
6. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188). Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials. Mouridsen HT; Andersen AP; Brincker H; Dombernowsky P; Rose C; Andersen KW NCI Monogr; 1986; (1):115-8. PubMed ID: 3534583 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV. Crivellari D; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Lindtner J; Fey MF; Senn HJ; Coates AS; Collins J; Goldhirsch A; J Clin Oncol; 2003 Dec; 21(24):4517-23. PubMed ID: 14673038 [TBL] [Abstract][Full Text] [Related]
10. Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience. Fisher B; Redmond C; Fisher ER; Wolmark N NCI Monogr; 1986; (1):35-43. PubMed ID: 3534589 [TBL] [Abstract][Full Text] [Related]
11. Extended adjuvant endocrine therapy of early breast cancer. Chowdhury S; Ellis P Curr Med Res Opin; 2005 Dec; 21(12):1985-95. PubMed ID: 16368050 [TBL] [Abstract][Full Text] [Related]
12. Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. Bonadonna G; Valagussa P; Tancini G; Rossi A; Brambilla C; Zambetti M; Bignami P; Di Fronzo G; Silvestrini R NCI Monogr; 1986; (1):45-9. PubMed ID: 3534590 [TBL] [Abstract][Full Text] [Related]
13. Endocrine management of breast cancer. Schneider PG; Jackisch C; Brandt B Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():115-27. PubMed ID: 7874188 [TBL] [Abstract][Full Text] [Related]
14. [A randomized clinical trial of adjuvant endocrine therapy after breast conserving surgery for early breast cancer. Cooperative Study Group for Breast Conserving Therapy]. Nakamura Y; Tominaga T; Nomura Y; Koyama H; Miura S; Morimoto T Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():217-25. PubMed ID: 8037485 [TBL] [Abstract][Full Text] [Related]
15. [Cox proportion hazard model multivariate analysis of prognosis of 1,484 axillary node-negative breast cancer patients]. Shen K; Shen Z; Han Q Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):221-4. PubMed ID: 10920903 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. ; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer. Cummings FJ; Gray R; Davis TE; Tormey DC; Harris JE; Falkson GG; Arseneau J NCI Monogr; 1986; (1):119-23. PubMed ID: 3534584 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of breast cancer: Southwest Oncology Group studies. Osborne CK; Rivkin SE; McDivitt RW; Green S; Stephens RL; Costanzi JJ; O'Bryan R NCI Monogr; 1986; (1):71-4. PubMed ID: 3534592 [TBL] [Abstract][Full Text] [Related]
19. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J; Polgár C; Péley G; Németh G Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099 [TBL] [Abstract][Full Text] [Related]
20. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer. Ejlertsen B; Mouridsen HT; Jensen MB; Bengtsson NO; Bergh J; Cold S; Edlund P; Ewertz M; de Graaf PW; Kamby C; Nielsen DL J Clin Oncol; 2006 Nov; 24(31):4956-62. PubMed ID: 17075113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]